未登录

S

Suna Sabuncuoğlu

hacettepe university

H指数:15

被引数:1,146

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exosomes in Toxicology: Emerging Biomarkers and Mechanistic Mediators of Toxicant-Induced Injury

毒理学中的外泌体：新兴生物标志物和毒物诱导损伤的机制介导者

Journal of Applied Toxicology

IF2.8

2026-09-210

PRE

Assessing Metabolic and Reproductive Consequences of Prenatal Paracetamol Exposure in Female CD1 Mice

评估产前对乙酰氨基酚暴露对雌性CD1小鼠代谢和生殖后果的影响

Journal of Applied Toxicology

IF2.8

2026-09-200

OAAI

Endocrine and Metabolism Modulating Effects of Paracetamol: From In Vitro Signaling to In Vivo Metabolic Reprogramming in Male Mice

对乙酰氨基酚的内分泌与代谢调节作用：从体外信号传导到雄性小鼠体内的代谢重编程

IF4.6

2026-04-050

PRE

Evaluation of Sphingolipid Metabolism in Silicosis Patients

硅沉着病患者鞘脂代谢的评估

Journal of Occupational and Environmental Medicine

IF1.4

2026-01-010

PRE

In vitro Investigation and Mass Spectrometric Characterization of Novel DNA Adducts of Sesquimustard

体外研究和新奇 Sesquimustard DNA 加合物的质谱表征

Chemico-Biological Interactions

IF5.4

2025-09-300

PRE

Design and Discovery of New Dual Carbonic Anhydrase IX and VEGFR-2 Inhibitors Based on the Benzenesulfonamide-Bearing 4-Thiazolidinones/2,4-Thiazolidinediones Scaffold

DRUG DEVELOPMENT RESEARCH

IF4.2

2024-12-110

PRE

New Ester-Containing Azole Derivatives With Potent Anti-Candida Effects: Synthesis, Antifungal Susceptibility, Cytotoxicity, and Molecular Modeling Studies

DRUG DEVELOPMENT RESEARCH

IF4.2

2024-11-170

PRE

Glutathione conjugation of sesquimustard: in vitro investigation of potential biomarkers

倍半体的谷胱甘肽缀合: 潜在生物标志物的体外研究

ARCHIVES OF TOXICOLOGY

IF6.9

2024-05-230

OAAI

Exercise capacity, inflammation, hemodynamic and macrovascular function in children with CF in different genders

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Effect of Second-Hand Tobacco Smoke Exposure on Lung Functions of Children with Chronic Lung Disease

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

Azole derivatives inhibit wildtype butyrylcholinesterase and its common mutants

DRUG DEVELOPMENT RESEARCH

IF4.2

2023-05-082

OAAI

Rational Design of New Monoterpene-Containing Azoles and Their Antifungal Activity

ANTIBIOTICS-BASEL

IF4.6

2023-04-279

OA

Comparison of melamine exposure by feeding practices in babies aged 0-6 months

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

IF4.2

2023-03-012

PRE

Potential of nafimidone derivatives against co-morbidities of epilepsy: In vitro, in vivo, and in silico investigations

DRUG DEVELOPMENT RESEARCH

IF4.2

2021-07-228

PREAI

Azole antifungal compounds could have dual cholinesterase inhibitory potential according to virtual screening, enzyme kinetics, and toxicity studies of an inhouse library

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2021-07-0112

PREAI

A Comprehensive Review on Oxysterols and Related Diseases

CURRENT MEDICINAL CHEMISTRY

IF3.5

2020-12-2966

PRE

Antibacterial azole derivatives: Antibacterial activity, cytotoxicity, and in silico mechanistic studies

DRUG DEVELOPMENT RESEARCH

IF4.2

2020-07-3010

PREAI

Evaluation of oxysterol levels of patients with silicosis by LC-MS/MS method

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2020-02-2718

PREAI

The increased neopterin content in turkish pediatric patients with sickle cell anemia

ANNALS OF HEMATOLOGY

IF2.4

2019-11-233

PREAI

Antifungal screening and in silico mechanistic studies of an in-house azole library

CHEMICAL BIOLOGY & DRUG DESIGN

IF3.3

2019-09-258

OAAI